Cogent Biosciences, Inc. (COGT) stock
COGTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$27.44−1.12 (-3.92%)
Close on Nov 16, 2026Market cap $4.76BP/E –Yield –
Cogent Biosciences gross margin
Gross margin is gross profit as a percentage of revenue.
No gross margin figures for Cogent Biosciences
Cogent Biosciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?